Product Information
BASAGLAR TEMPO PEN 100 UNIT/ML is a brand product labeled by Eli Lilly and Company, priced at $20.9549 per ML under NDC 00002821405. Its NADAC has been published 174 times since Feb 15, 2023.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002821405
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
11/19/2025
Active Ingredients
INSULIN GLARGINEApproval Type
Biologic (BLA)
FDA Application
BLA205692On Market Since
12/16/2015
Pharmacological Classes
Price Statistics
The NADAC for BASAGLAR TEMPO PEN 100 UNIT/ML has been published 174 times since Feb 15, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.9549 per ML |
|---|---|
| All-time high | $20.9699 (May 14, 2025) |
| All-time low | $20.8623 (Mar 20, 2024) |
| 52-week high | $20.9592 |
| 52-week low | $20.9466 |
| Median price | $20.9446 |
| Average price | $20.9340 |
| Largest weekly change | -0.2% (Mar 20, 2024) |
| Weeks tracked | 174 |
| Tracking since | Feb 15, 2023 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
+0.0%
3Y
+0.3%
5Y
N/A
All
+0.1%
Last surveyed Sep 9, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Insulin glargine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BASAGLAR TEMPO PEN 100 UNIT/ML?
The current National Average Drug Acquisition Cost (NADAC) for BASAGLAR TEMPO PEN 100 UNIT/ML, manufactured by Eli Lilly and Company, is $20.9549 per ML (NDC 00002821405), effective Sep 9, 2026.
How has the price of BASAGLAR TEMPO PEN 100 UNIT/ML changed over time?
Over the history we have for it, the NADAC for BASAGLAR TEMPO PEN 100 UNIT/ML has held within roughly two percent of its current level. It has been tracked across 174 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for BASAGLAR TEMPO PEN 100 UNIT/ML?
Since Feb 15, 2023, the NADAC for BASAGLAR TEMPO PEN 100 UNIT/ML has ranged from a low of $20.8623 (Mar 20, 2024) to a high of $20.9699 (May 14, 2025), with a median of $20.9446 per ML.
Are there cheaper alternatives to BASAGLAR TEMPO PEN 100 UNIT/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BASAGLAR 100 UNIT/ML KWIKPEN, is $20.9351 per ML — about 0% below BASAGLAR TEMPO PEN 100 UNIT/ML.
Who manufactures BASAGLAR TEMPO PEN 100 UNIT/ML?
BASAGLAR TEMPO PEN 100 UNIT/ML (NDC 00002821405) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.